CUNY: New Clue Emerges In Fight Against Triple-Negative Breast Cancer
October 07, 2022
October 07, 2022
NEW YORK, Oct. 7 (TNSjou) -- The City University of New York's Graduate Center issued the following news:
* * *
A study led by Professor Jill Bargonetti finds mutant protein key to cancer cell survival and may offer new biomarkers for PARP-inhibitor therapy.
* * *
Triple-negative breast cancer is an aggressive form of cancer that most often affects Black and Hispanic women and women under 40. There are fewer targeted therapies for this kin . . .
* * *
A study led by Professor Jill Bargonetti finds mutant protein key to cancer cell survival and may offer new biomarkers for PARP-inhibitor therapy.
* * *
Triple-negative breast cancer is an aggressive form of cancer that most often affects Black and Hispanic women and women under 40. There are fewer targeted therapies for this kin . . .